Use of Pre-Infusion Serum Uric Acid Levels as a Biomarker for Infusion Reaction Risk in Patients on Pegloticase

INTRODUCTION: The aim of this work is to evaluate the impact of the timing of pre-infusion serum uric acid (sUA) test results for use in applying stopping rules for pegloticase to identify patients at risk for infusion reactions (IRs) while on therapy. METHODS: Data from the phase 3 clinical trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Keenan, Robert T., Baraf, Herbert S. B., LaMoreaux, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513953/
https://www.ncbi.nlm.nih.gov/pubmed/30875075
http://dx.doi.org/10.1007/s40744-019-0151-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513953/
https://www.ncbi.nlm.nih.gov/pubmed/30875075
http://dx.doi.org/10.1007/s40744-019-0151-9

Ejemplares similares